Navigation Links
Gene Therapy Pioneers Win $1 Million Sanford Lorraine Cross Award
Date:12/5/2018

Two women with a vision to make the blind see were the winners of the inaugural $1 million Sanford Lorraine Cross Award.

Jean Bennett, M.D., Ph.D., and Katherine A. High, M.D., whose work with the RPE65 mutation has reversed an inherited form of blindness, accepted the award on Dec. 4 at Sanford Health, headquartered in Sioux Falls, South Dakota.

“I want to thank the Sanford Health system for rewarding innovation,” said High. “There were many days we were discouraged, so it’s so wonderful for an award to be given for people who made it across the finish line.”

Bennett expressed her gratitude and said that the patients are the real pioneers.

Four finalists competed for the prize, intended to reward contributions to medicine, science and innovation. The women were chosen in an 8-1 vote of the Sanford International Board.

“No matter who we picked, it was going to be a great winner. They are all winners. But even more, we are all winners,” said Andy North, president of the Sanford International Board. The board heard from the candidates in a private presentation on Tuesday morning, with the winner announced at a ceremony that evening.

Gene therapy quickly stood out as the field of candidates was narrowed, said David Pearce, Ph.D., president of research at Sanford Health, who noted that these four finalists helped lay the groundwork for much of the innovative work that is being explored now.

“We want to make a difference. It’s a culture that delivers on the idea that if you make a promise here, that’s a promise kept,” said Kelby Krabbenhoft, president and CEO of Sanford Health, during the award ceremony. “Let’s start curing things. Let’s make a difference. The world will be better because of you.”

Bennett and High pioneered the gene therapy for the RPE65 mutation, took it to clinical trials and then received the first FDA approval of a gene therapy for a genetic disease. High also co-founded Spark Therapeutics, a fully integrated, commercial gene therapy company working to accelerate the timeline for bringing new gene therapies to market. Bennett is a professor of ophthalmology at the University of Pennsylvania and a scientific co-founder of Spark Therapeutics, and High is president and head of research and development at Spark Therapeutics.

The other finalists were:

  • Brian Kaspar, Ph.D., whose lab discovered a gene replacement therapy approach that seeks to change the course of spinal muscular atrophy (SMA) by addressing its genetic cause. SMA is a devastating disease that robs babies of basic muscle functions, like breathing and swallowing, and in its most severe form (Type 1), usually leads to death by age 2. An initial clinical trial using the AAV9 vector to treat SMA Type 1 demonstrated a dramatic survival benefit and rapid improvement in motor milestones. Kaspar is the scientific founder and chief scientific officer of AveXis, a gene therapy company that was acquired by Novartis in 2018.
  • James M. Wilson, M.D., Ph.D., whose work paved the way for many groups to safely move promising gene therapies for inherited and acquired diseases through the translational pipeline internationally. He is the director of the Gene Therapy Program, the Rose H. Weiss Professor and Director of the Orphan Disease Center, and a professor of Medicine and Pediatrics in the Perelman School of Medicine at the University of Pennsylvania. In 2008, Wilson and the University of Pennsylvania cofounded REGENXBIO, Inc., a clinical-stage biotech company designing gene therapy products.

Candidates for the award were filtered through nominations from the public and a computer algorithm that sifted through medical publications in search of great discoveries. An interdisciplinary scientific advisory board identified top areas of innovation and the candidates were narrowed down to the top four.

The award is named after the Lorraine Cross, a symbol recognized around the world synonymous for those who take action for their passions. In recent history, Sanford Health has used it to symbolize innovation in health care.

About Sanford Health
Sanford Health is one of the largest health care systems in the nation with 44 hospitals and nearly 1,400 physicians in nine states and nine countries. Headquartered in Sioux Falls, South Dakota, and serving the Upper Midwest, Sanford Health is dedicated to several initiatives, including global clinics, genomic medicine and specialized centers researching cures for type 1 diabetes, breast cancer and other diseases. Sanford Health has nearly 30,000 employees, making it the largest employer in the Dakotas. Nearly $1 billion in gifts from philanthropist Denny Sanford over the past decade have transformed how Sanford Health can improve the human condition. For information, visit http://www.sanfordhealth.org.

Read the full story at https://www.prweb.com/releases/gene_therapy_pioneers_win_1_million_sanford_lorraine_cross_award/prweb15954732.htm.


'/>"/>
Source: PRWeb
Copyright©2018 Vocus, Inc.
All rights reserved


Related medicine technology :

1. Actinium Pharmaceuticals Clinical Results to be Presented at 8th International Symposium on Targeted Alpha Therapy Conference
2. Puerto Ricos Caribbean Imaging and Radiation Therapy Center Orders Elektas New Versa HD System for Treatment of Cancer Patients
3. New Data Show Long-Term Benefit of Transcranial Magnetic Stimulation in Difficult-to-Treat Patients with Depression using NeuroStar TMS Therapy System
4. The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients
5. BioElectronics and Pulsed Shortwave Therapy Make Progress
6. Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions
7. OrbusNeich Launches Worlds First Dual Therapy Stent That Addresses Challenges of Delayed Coronary Artery Healing Associated with Monotherapy Drug Eluting Stents
8. Leeds St Jamess Institute of Oncology Acquires Two Elekta Versa HD Radiotherapy Systems
9. Rheumatoid Arthritis Patients are Moderately to Highly Satisfied with Their Current Drug Therapy, Rating Conventional DMARDs Highest on Ease of Use and Cost
10. Charlotte Based Compression And Vacuum Therapy Technology Helps Train Cyclist In Race Across America
11. Positive Generex Data Underscores Cancer Immunotherapy Forecast Issued by Citi
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2019)... ... May 22, 2019 , ... CBDNhance, ... products, Ultra-Relief and Ultra-Relax, that are designed to increase the benefits of CBD, ... CBD, but instead contain terpenes and other natural ingredients that have been shown ...
(Date:5/22/2019)... ... May 22, 2019 , ... New research places Fort Worth in the ... five years before in 2013. According to the Gallup National Health and Well-Being Index, ... , In 2013, Fort Worth’s equivalent rank was 185th out of 190 reported metro ...
(Date:5/22/2019)... ... May 22, 2019 , ... Strive ... announced the appointment of American Psychiatric Association president-elect Jeffrey Geller, MD to its ... American Psychiatric Association (APA), the largest psychiatric association in the world with more ...
Breaking Medicine Technology:
(Date:5/23/2019)... ... May 23, 2019 , ... Summit BHC (Summit), a ... its seventeenth treatment center, Bel Aire Recovery Center. Located in the suburbs of ... State. The facility is located in the natural landscape of the beautiful Kansas ...
(Date:5/23/2019)... ... , ... Carrie Romandine, RevSpring’s vice president of platform management, was named one ... , This is the fourth year that HDM has recognized women in Healthcare ... following professional categories:, CIOs/HIT executives at provider organizations , ...
(Date:5/23/2019)... Calif. (PRWEB) , ... May 23, 2019 , ... ... Qualia line of nootropic products, has recently partnered with Emerson Ecologics. Qualia Mind, ... and their online Practitioner dispensary platform Wellevate. With Emerson’s extensive nearly 40 year ...
(Date:5/22/2019)... ... May 22, 2019 , ... In the U.S. in 2014, according to ... procedures, the last step in the in vitro fertilization (IVF) process. This represents an ... Dr. Mark P. Trolice, Director of Fertility CARE: The IVF Center , emphasizes ...
(Date:5/22/2019)... ... May 22, 2019 , ... Antiperspirant ... designed to reduce groin sweat and friction. The powder comes in a compact ... maximum efficacy, convenience, and portability. , “Groin sweat and the chafing it can ...
Breaking Medicine News(10 mins):